Product Images Cyclobenzaprine Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Cyclobenzaprine Hydrochloride NDC 53002-0521 by Rpk Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Image - 7d5e3bad 7f85 4e2b 81c5 7981c456e45f 01
IMAGE - 7d5e3bad 7f85 4e2b 81c5 7981c456e45f 02
This is a table showing the results of a study on the effects of Cyclobenzaprine HCI Tablets on symptoms such as drowsiness, dry mouth, fatigue, and headache. The study involved two groups of patients taking 5mg and 10mg of the medication and a third group taking a placebo. The results show the percentage of patients in each group who experienced each symptom.*
IMAGE - 7d5e3bad 7f85 4e2b 81c5 7981c456e45f 03
This text provides information about the side effects observed during clinical studies and surveillance programs with Cyclobenzaprine HCI Tablets at a dosage of 10mg. The most common side effect reported in clinical studies was drowsiness (39%), followed by dry mouth (2%) and dizziness (1%). The surveillance program also showed high incidence rates for drowsiness (16%), followed by dry mouth (7%) and dizziness (3%).*
Label Image - lbl530020521
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.